Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 8
Submit an article Journal homepage
59
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects

B. A. John Department of Metabolism and Pharmacokinetics, Huntingdon Life Sciences, Huntingdon PE28 4HS, UK
,
R. R. Brodie Klinge Pharma GmbH, 81673, Munich, Germany
,
G. A. Baldock Department of Metabolism and Pharmacokinetics, Huntingdon Life Sciences, Huntingdon PE28 4HS, UK
,
A. McBurney Klinge Pharma GmbH, 81673, Munich, Germany
,
L. F. Chasseaud Department of Metabolism and Pharmacokinetics, Huntingdon Life Sciences, Huntingdon PE28 4HS, UK
,
P. Jank Klinge Pharma GmbH, 81673, Munich, Germany
&
A. von Nieciecki Department of Metabolism and Pharmacokinetics, Huntingdon Life Sciences, Huntingdon PE28 4HS, UK
 show all
Pages 699-713 | Published online: 22 Sep 2008

References

  • AHLEM N, L. M., STAAB, H.-J., LOSER, R., SEIBEL, K. and HUBER, H.-J., 1988, Inhibition of growth of human cancer by intermittent exposure to the antiestrogen droloxifene. Tumordiagnostik und Therapie, 9, 41–46.
  • GIBSON, G. G. and SKETT, P., 1986, Introduction to Drug Metabolism (London: Chapman & Hall). GRILL, H. J. and PoLLow, K., 1991, Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. American Journal of Clinical Oncology, 14 (suppl. 2), S21—S29.
  • HASMANN, M., RATTEL, B. and LOSE R., 1994, Preclinical data for droloxifene. Cancer Letters, 84, 101–116.
  • HIROM, P. C., IDLE, J. R. and MILLBURN, P., 1977, Comparative aspects of the biosynthesis and excretion of xenobiotic conjugates by non-primate mammals. In D. V. Parke and R. L. Smith (eds), Drug Metabolism: From Microbe to Man (London: Taylor & Francis), pp. 299–329.
  • IARC, 1996, Droloxifene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 66 (Lyon: IARC) pp. 241–251.
  • JANK, P., KERN, D., HUBER, H. J. and STANISLAUS, F. D., 1987, Direct determination of droloxifene in serum using HPLC with precolumn switching, post-column photochemical derivatisation and fluorescence detection. In J. M. Aiache and J. Hirtz (eds), Proceedings of the 3rd European Congress of Biopharmaceutics and Pharmacokinetics, Clermont-Ferrand, vol. 1, pp. 511–520.
  • LIEN, E. A., ANKER, G., LONNING, P. E. and UELAND, D. M., 1995, Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. Therapeutic Drug Monitoring, 17, 259–265.
  • LONNING, P. E., LIEN, E. A., LUNDGREN, S. and KVINNSLAND, S., 1992, Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clinical Pharmacokinetics, 22, 327–358.
  • LOSER, R., SEIBEL, K., LIEHN, H. D. and STAAB, H. J., 1986, Pharmacology and toxicology of the antiestrogen, droloxifene. Control of Oncology, 24, 64–72.
  • LOSER, R., SEIBEL, K., Roos, W. and EPPENBERGER, U., 1985, In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen. European Journal Cancer and Clinical Oncology, 21, 985–990.
  • NICKERSON, D. F., TESS, D. A. and TOLER, S. M., 1997, First-pass metabolism and biliary recirculation of droloxifene in the female Sprague—Dawley rat. Xenobiotica, 27, 257–264.
  • O'DONNELL, J. P., KiiosiA, N. B. and DALVIE, D. K., 1998, Metabolism of droloxifene in the CD-1 mouse, Fischer-344 rat and cynomolgus monkey. Xenobiotica, 28, 153–166.
  • POON, G. K., CHUI, Y. C., MCCAGUE, R., LONNING, P. E., FENG, R., ROWLANDS, M. G. and JARMAN, M., 1993, Analysis of Phase 1 and Phase II metabolites of tamoxifen in breast cancer patients. Drug Metabolism and Disposition, 21, 1119–1124.
  • RAUSCHNING, W. and PRITCHARD, K. I., 1994, Droloxifene: a new antiestrogen: its role in metastatic breast cancer. Breast Cancer Research and Treatment, 31, 83–94.
  • SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451–523.
  • TANAKA, Y., SEKIGUCHI, M., SAWAMOTO, T., HATA, T., Esumi, Y., SUGAI, S. and NINOMIYA, S., 1994, Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. European Journal of Drug Metabolism and Pharmacokinetics, 19, 47–58.
  • TARAS, T. L., WURZ, G. T., LINARES, G. R. and DEGREGORIO, M. W., 2000, Clinical pharmacokinetics of toremifene. Clinical Pharmacokinetics, 39, 327–334.
  • WHITE, I. N. H., DEMATTEIS, F., DAVIES, A., SMITH, L. L., CROFTON-SLEIGH, C., VENITT, S., HEWER, A. and PHILLIPS, D. H., 1992, Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis, 13, 2197–2203.
  • WISEMAN, H., 1994, Tamoxifen: Molecular Basis of Use in Cancer Treatment and Prevention (Chichester: Wiley).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.